Gritstone bio Inc. (NASDAQ: GRTS) Stock Information | RedChip

Gritstone bio Inc. (NASDAQ: GRTS) Listen to this Section


$0.51
-0.0201 ( -3.79% ) 1.4M

Gritstone Bio Inc is a biotechnology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types and infectious diseases. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors, which includes GRANITE, SLATE, and CORAL, among others.

Market Data


Open


$0.51

Previous close


$0.53

Volume


1.4M

Market cap


$59.07M

Day range


$0.50 - $0.58

52 week range


$0.45 - $3.33

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
3 Insider transactions 2 Apr 30, 2024
ars Annual reports 1 Apr 29, 2024
def Proxies and info statements 7 Apr 29, 2024
8-k 8K-related 13 Apr 29, 2024
8-k 8K-related 20 Apr 02, 2024
8-k 8K-related 13 Apr 01, 2024
8-k 8K-related 13 Mar 05, 2024
10-k Annual reports 102 Mar 05, 2024
8-k 8K-related 14 Feb 29, 2024
8-k 8K-related 14 Feb 12, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.